Medieos Lifesciences LLP

Several wholesale suppliers of generic medicines are available in Jaipur, including Medieos Lifesciences LLP

Several wholesale suppliers of generic medicines are available in Jaipur, including Medieos Lifesciences LLP

Several wholesale suppliers of generic medicines are available in Jaipur, including Medieos Lifesciences LLP

Several wholesale suppliers of generic medicines are available in Jaipur, including Medieos Lifesciences LLP

Several wholesale suppliers of generic medicines are available in Jaipur, including Medieos Lifesciences LLP

Several wholesale suppliers of generic medicines are available in Jaipur, including Medieos Lifesciences LLP

Several wholesale suppliers of generic medicines are available in Jaipur, including Medieos Lifesciences LLP

Tacrolimus Capsules are potent immunosuppressive agents widely used in India and globally to prevent organ transplant rejection and to manage certain autoimmune and inflammatory disorders. Tacrolimus is a calcineurin inhibitor that reduces T-cell activation and modulates the immune response.
11. CONTRAINDICATIONS

• Hypersensitivity to Tacrolimus or excipients

• Severe hepatic impairment without dose adjustment

• Uncontrolled infections

• Co-administration with certain CYP3A4 inhibitors without monitoring

12. DRUG INTERACTIONS

• CYP3A4 inhibitors: Ketoconazole, erythromycin → increase Tacrolimus levels

• CYP3A4 inducers: Rifampicin, phenytoin → decrease efficacy

• Nephrotoxic drugs: Increased risk of renal toxicity

• Immunosuppressants: Monitor for additive effects

• Herbal supplements: St. John’s Wort reduces Tacrolimus levels

13. USE IN SPECIAL POPULATIONS Pregnancy

• Category C; use only if benefits outweigh risks

Breastfeeding

• Avoid systemic exposure; monitor infant

Pediatric

• Weight-based dosing under specialist supervision

Elderly

• Monitor renal and hepatic function; dose adjustments may be needed

14. STORAGE AND HANDLING

• Store at 25°C or below

• Protect from light and moisture

• Keep in original packaging

• Out of reach of children

• Avoid storing in bathrooms or humid environments

11. CONTRAINDICATIONS

• Hypersensitivity to Tacrolimus or excipients

• Severe hepatic impairment without dose adjustment

• Uncontrolled infections

• Co-administration with certain CYP3A4 inhibitors without monitoring

12. DRUG INTERACTIONS

• CYP3A4 inhibitors: Ketoconazole, erythromycin → increase Tacrolimus levels

• CYP3A4 inducers: Rifampicin, phenytoin → decrease efficacy

• Nephrotoxic drugs: Increased risk of renal toxicity

• Immunosuppressants: Monitor for additive effects

• Herbal supplements: St. John’s Wort reduces Tacrolimus levels

13. USE IN SPECIAL POPULATIONS Pregnancy

• Category C; use only if benefits outweigh risks

Breastfeeding

• Avoid systemic exposure; monitor infant

Pediatric

• Weight-based dosing under specialist supervision

Elderly

• Monitor renal and hepatic function; dose adjustments may be needed

14. STORAGE AND HANDLING

• Store at 25°C or below

• Protect from light and moisture

• Keep in original packaging

• Out of reach of children

• Avoid storing in bathrooms or humid environments

Tacrolimus Capsules are potent immunosuppressive agents widely used in India and globally to prevent organ transplant rejection and to manage certain autoimmune and inflammatory disorders. Tacrolimus is a calcineurin inhibitor that reduces T-cell activation and modulates the immune response.
11. CONTRAINDICATIONS

• Hypersensitivity to Tacrolimus or excipients

• Severe hepatic impairment without dose adjustment

• Uncontrolled infections

• Co-administration with certain CYP3A4 inhibitors without monitoring

12. DRUG INTERACTIONS

• CYP3A4 inhibitors: Ketoconazole, erythromycin → increase Tacrolimus levels

• CYP3A4 inducers: Rifampicin, phenytoin → decrease efficacy

• Nephrotoxic drugs: Increased risk of renal toxicity

• Immunosuppressants: Monitor for additive effects

• Herbal supplements: St. John’s Wort reduces Tacrolimus levels

13. USE IN SPECIAL POPULATIONS Pregnancy

• Category C; use only if benefits outweigh risks

Breastfeeding

• Avoid systemic exposure; monitor infant

Pediatric

• Weight-based dosing under specialist supervision

Elderly

• Monitor renal and hepatic function; dose adjustments may be needed

14. STORAGE AND HANDLING

• Store at 25°C or below

• Protect from light and moisture

• Keep in original packaging

• Out of reach of children

• Avoid storing in bathrooms or humid environments

11. CONTRAINDICATIONS

• Hypersensitivity to Tacrolimus or excipients

• Severe hepatic impairment without dose adjustment

• Uncontrolled infections

• Co-administration with certain CYP3A4 inhibitors without monitoring

12. DRUG INTERACTIONS

• CYP3A4 inhibitors: Ketoconazole, erythromycin → increase Tacrolimus levels

• CYP3A4 inducers: Rifampicin, phenytoin → decrease efficacy

• Nephrotoxic drugs: Increased risk of renal toxicity

• Immunosuppressants: Monitor for additive effects

• Herbal supplements: St. John’s Wort reduces Tacrolimus levels

13. USE IN SPECIAL POPULATIONS Pregnancy

• Category C; use only if benefits outweigh risks

Breastfeeding

• Avoid systemic exposure; monitor infant

Pediatric

• Weight-based dosing under specialist supervision

Elderly

• Monitor renal and hepatic function; dose adjustments may be needed

14. STORAGE AND HANDLING

• Store at 25°C or below

• Protect from light and moisture

• Keep in original packaging

• Out of reach of children

• Avoid storing in bathrooms or humid environments

Tacrolimus Capsules are potent immunosuppressive agents widely used in India and globally to prevent organ transplant rejection and to manage certain autoimmune and inflammatory disorders. Tacrolimus is a calcineurin inhibitor that reduces T-cell activation and modulates the immune response.
11. CONTRAINDICATIONS

• Hypersensitivity to Tacrolimus or excipients

• Severe hepatic impairment without dose adjustment

• Uncontrolled infections

• Co-administration with certain CYP3A4 inhibitors without monitoring

12. DRUG INTERACTIONS

• CYP3A4 inhibitors: Ketoconazole, erythromycin → increase Tacrolimus levels

• CYP3A4 inducers: Rifampicin, phenytoin → decrease efficacy

• Nephrotoxic drugs: Increased risk of renal toxicity

• Immunosuppressants: Monitor for additive effects

• Herbal supplements: St. John’s Wort reduces Tacrolimus levels

13. USE IN SPECIAL POPULATIONS Pregnancy

• Category C; use only if benefits outweigh risks

Breastfeeding

• Avoid systemic exposure; monitor infant

Pediatric

• Weight-based dosing under specialist supervision

Elderly

• Monitor renal and hepatic function; dose adjustments may be needed

14. STORAGE AND HANDLING

• Store at 25°C or below

• Protect from light and moisture

• Keep in original packaging

• Out of reach of children

• Avoid storing in bathrooms or humid environments

11. CONTRAINDICATIONS

• Hypersensitivity to Tacrolimus or excipients

• Severe hepatic impairment without dose adjustment

• Uncontrolled infections

• Co-administration with certain CYP3A4 inhibitors without monitoring

12. DRUG INTERACTIONS

• CYP3A4 inhibitors: Ketoconazole, erythromycin → increase Tacrolimus levels

• CYP3A4 inducers: Rifampicin, phenytoin → decrease efficacy

• Nephrotoxic drugs: Increased risk of renal toxicity

• Immunosuppressants: Monitor for additive effects

• Herbal supplements: St. John’s Wort reduces Tacrolimus levels

13. USE IN SPECIAL POPULATIONS Pregnancy

• Category C; use only if benefits outweigh risks

Breastfeeding

• Avoid systemic exposure; monitor infant

Pediatric

• Weight-based dosing under specialist supervision

Elderly

• Monitor renal and hepatic function; dose adjustments may be needed

14. STORAGE AND HANDLING

• Store at 25°C or below

• Protect from light and moisture

• Keep in original packaging

• Out of reach of children

• Avoid storing in bathrooms or humid environments

Tacrolimus Capsules are potent immunosuppressants widely used in India for preventing organ transplant rejection and managing certain autoimmune disorders. Tacrolimus is a calcineurin inhibitor that acts on T-lymphocytes, suppressing the immune system to prevent graft rejection and reduce inflammatory responses.
11. CONTRAINDICATIONS

• Hypersensitivity to Tacrolimus or excipients

• Severe hepatic impairment without dose adjustment

• Uncontrolled infections

• Concurrent use of certain CYP3A4 inhibitors without monitoring

12. DRUG INTERACTIONS

• CYP3A4 inhibitors: Ketoconazole, erythromycin → increase Tacrolimus levels

• CYP3A4 inducers: Rifampicin, phenytoin → reduce efficacy

• Nephrotoxic drugs: Increased risk of kidney toxicity

• Other immunosuppressants: Monitor for additive effects

• Herbal supplements: St. John’s Wort decreases Tacrolimus levels

13. USE IN SPECIAL POPULATIONS Pregnancy

• Category C; use only if benefits outweigh risks

Breastfeeding

• Avoid systemic exposure; monitor infant

Pediatric

• Weight-based dosing; regular blood monitoring

Elderly

• Monitor renal and hepatic function; dose adjustments may be necessary

14. STORAGE AND HANDLING

• Store at 25°C or below

• Protect from light and moisture

• Keep in original packaging

• Out of reach of children

• Avoid humid storage conditions

FREQUENTLY ASKED QUESTIONS (FAQ) Q1. What are Tacrolimus Capsules used for?

Prevent organ transplant rejection and manage autoimmune disorders.

Q2. How does Tacrolimus work?

Inhibits calcineurin, preventing T-cell activation and immune-mediated tissue damage.

Q3. Can Tacrolimus be used long-term?

Yes, especially for post-transplant therapy.

Q4. How should Tacrolimus be taken?

On an empty stomach, 1 hour before or 2 hours after meals.

Q5. Are there side effects?

Common: tremors, headache, nausea; rare: nephrotoxicity, neurotoxicity, infections.

Q6. Can Tacrolimus be used in pregnancy?

Only if benefits outweigh risks; under specialist supervision.

Q7. Can children take Tacrolimus?

Yes, with weight-based dosing and monitoring.

Q8. What monitoring is required?

Blood levels, renal and liver function, blood pressure, glucose.

Q9. Can Tacrolimus interact with other drugs?

Yes, especially CYP3A4 inhibitors/inducers, nephrotoxic drugs, and immunosuppressants.

Q10. Can Tacrolimus capsules be supplied in bulk?

Yes, bulk and institutional packs are available for clinics and hospitals.

Q11. How should Tacrolimus be stored?

At 25°C, protected from light and moisture.

Q12. Are all strengths interchangeable?

No; dosing depends on patient weight, condition, and blood levels.

Q13. Can Tacrolimus be used for autoimmune skin disorders?

Yes, under specialist supervision.

Q14. Is Tacrolimus suitable for outpatient clinics?

Yes, oral capsules are convenient for outpatient and follow-up therapy.

Q15. How soon should blood levels be checked?

Typically after 3–5 days of therapy or dose adjustment, then regularly as prescribed.

Tacrolimus Capsules are potent immunosuppressants widely used in India for preventing organ transplant rejection and managing certain autoimmune disorders. Tacrolimus is a calcineurin inhibitor that acts on T-lymphocytes, suppressing the immune system to prevent graft rejection and reduce inflammatory responses.
11. CONTRAINDICATIONS

• Hypersensitivity to Tacrolimus or excipients

• Severe hepatic impairment without dose adjustment

• Uncontrolled infections

• Concurrent use of certain CYP3A4 inhibitors without monitoring

12. DRUG INTERACTIONS

• CYP3A4 inhibitors: Ketoconazole, erythromycin → increase Tacrolimus levels

• CYP3A4 inducers: Rifampicin, phenytoin → reduce efficacy

• Nephrotoxic drugs: Increased risk of kidney toxicity

• Other immunosuppressants: Monitor for additive effects

• Herbal supplements: St. John’s Wort decreases Tacrolimus levels

13. USE IN SPECIAL POPULATIONS Pregnancy

• Category C; use only if benefits outweigh risks

Breastfeeding

• Avoid systemic exposure; monitor infant

Pediatric

• Weight-based dosing; regular blood monitoring

Elderly

• Monitor renal and hepatic function; dose adjustments may be necessary

14. STORAGE AND HANDLING

• Store at 25°C or below

• Protect from light and moisture

• Keep in original packaging

• Out of reach of children

• Avoid humid storage conditions

FREQUENTLY ASKED QUESTIONS (FAQ) Q1. What are Tacrolimus Capsules used for?

Prevent organ transplant rejection and manage autoimmune disorders.

Q2. How does Tacrolimus work?

Inhibits calcineurin, preventing T-cell activation and immune-mediated tissue damage.

Q3. Can Tacrolimus be used long-term?

Yes, especially for post-transplant therapy.

Q4. How should Tacrolimus be taken?

On an empty stomach, 1 hour before or 2 hours after meals.

Q5. Are there side effects?

Common: tremors, headache, nausea; rare: nephrotoxicity, neurotoxicity, infections.

Q6. Can Tacrolimus be used in pregnancy?

Only if benefits outweigh risks; under specialist supervision.

Q7. Can children take Tacrolimus?

Yes, with weight-based dosing and monitoring.

Q8. What monitoring is required?

Blood levels, renal and liver function, blood pressure, glucose.

Q9. Can Tacrolimus interact with other drugs?

Yes, especially CYP3A4 inhibitors/inducers, nephrotoxic drugs, and immunosuppressants.

Q10. Can Tacrolimus capsules be supplied in bulk?

Yes, bulk and institutional packs are available for clinics and hospitals.

Q11. How should Tacrolimus be stored?

At 25°C, protected from light and moisture.

Q12. Are all strengths interchangeable?

No; dosing depends on patient weight, condition, and blood levels.

Q13. Can Tacrolimus be used for autoimmune skin disorders?

Yes, under specialist supervision.

Q14. Is Tacrolimus suitable for outpatient clinics?

Yes, oral capsules are convenient for outpatient and follow-up therapy.

Q15. How soon should blood levels be checked?

Typically after 3–5 days of therapy or dose adjustment, then regularly as prescribed.